1
ApoGlyx patent applications granted in new countries
ApoGlyx has applied for two patents covering Aquaporin-9 inhibitor technology. A first patent has been granted in the USA in 2018, and in 2020 in Australia, China, and Japan. A second patent has also been granted in the USA in August 2020.
2
Find out what the news is saying about Sepsis and it's role in Covid-19
Read a blog article by Jiqing Hansen on Supertrends entitled “The new challenge in fighting old sepsis”.
...